Skip to main content

You are here:


Improving lives through research

St. Vincent’s Healthcare Group (SVHG) recognises that excellence in research underpins excellence in patient care. Research contributes to the next generation of doctors, nurses and allied health professionals, and by leading in clinical and translational research, the Group and its hospitals play a critical role in the health of the nation.

In partnership with UCD, SVHG and its investigators have long established an international reputation for clinical research. Our research is routinely published in leading influential scientific and medical journals and is contributing to changing patient care. Many of our investigators are globally recognised leaders whose research continues to change outcomes for patients. We have achieved major success in research by creating an environment which is supportive to investigators whilst ensuring that all research activity is carried out to the highest ethical and legal standards.

Our research standards

We strive to advance medical care for all our patients by supporting and enabling high-quality clinical research.
We are committed to ensuring that all studies involving human subjects will be carried out in a way which protects the interests of the subjects, whilst ensuring that healthcare is continuously improved. When carrying out research on humans all investigators operate to the accepted international standards enshrined within:

  • CPMP/ICH/135/95/: good clinical practice
  • EU CT Directive 2001/20/EC
  • GCP Commission Directive 2005/28/EC
  • S.I. Nos. 190 of 2004, 878 of 2004 and 374 of 2006
  • and all other applicable national and international legislation

All studies are subject to detailed review by the hospital Research Ethics Committee, and in the case of medicines by the National Competent Authority, the Health Products Regulatory Authority (HPRA).

Our commitment to quality and regulatory compliance is achieved through our dedicated clinical research quality management system which includes:

  • a dedicated quality and regulatory affairs manager
  • a bespoke new staff induction and orientation programme to ensure all staff and investigators are aware of their responsibilities
  • a suite of 70+ policy documents, SOPS and work instructions
  • centralised management of regulatory approvals to the HPRA.
  • a programme of internal monitoring and audit
  • inspections from external bodies including HPRA, FDA and JCI.

Useful links

Do you want to contribute to on-going medical research? Why not take part in one of our clinical trials?